| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.38▼ | 1.37▼ | 1.38▼ | 1.40▼ | 1.48▼ |
| MA10 | 1.37▼ | 1.37▼ | 1.38▼ | 1.47▼ | 1.64▼ |
| MA20 | 1.38▼ | 1.39▼ | 1.40▼ | 1.48▼ | 1.40▼ |
| MA50 | 1.40▼ | 1.43▼ | 1.47▼ | 1.65▼ | 1.31▲ |
| MA100 | 1.46▼ | 1.48▼ | 1.47▼ | 1.38▼ | 2.36▼ |
| MA200 | 1.48▼ | 1.52▼ | 1.63▼ | 1.33▲ | 2.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.001▲ | 0.001▲ | -0.009▼ | -0.003▼ |
| RSI | 45.714▼ | 44.441▼ | 42.892▼ | 41.456▼ | 48.343▼ |
| STOCH | 55.192 | 61.538 | 41.799 | 20.725 | 19.141▼ |
| WILL %R | -46.154 | -46.154 | -73.077 | -83.784▼ | -82.443▼ |
| CCI | -24.762 | -23.333 | -66.937 | -110.302▼ | -60.068 |
| CDL | $MRKR Doji Candlestick Pattern Detected | Set Alert |
|
Friday, March 06, 2026 08:25 AM
Merck reported breakthrough pivotal Phase 3 results for Keytruda-based combinations in renal cell carcinoma and ovarian cancer. The company also announced positive clinical trial data for a new HIV ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/03/26 | 1.37 | 1.415 | 1.33 | 1.38 | 50,086 |
| 05/03/26 | 1.43 | 1.4859 | 1.3501 | 1.39 | 121,759 |
| 04/03/26 | 1.39 | 1.4954 | 1.37 | 1.44 | 114,438 |
| 03/03/26 | 1.38 | 1.42 | 1.32 | 1.37 | 144,165 |
| 02/03/26 | 1.44 | 1.47 | 1.36 | 1.40 | 101,787 |
| 27/02/26 | 1.55 | 1.5993 | 1.47 | 1.48 | 65,667 |
| 26/02/26 | 1.55 | 1.63 | 1.5001 | 1.58 | 201,447 |
| 25/02/26 | 1.64 | 1.69 | 1.53 | 1.55 | 121,796 |
| 24/02/26 | 1.45 | 1.64 | 1.45 | 1.63 | 274,469 |
| 23/02/26 | 1.45 | 1.4999 | 1.41 | 1.47 | 0 |
|
|
||||
|
|
||||
|
|